Literature DB >> 19296794

Identifying existing health care services that do not provide value for money.

Adam G Elshaug1, John R Moss, Peter Littlejohns, Jonathan Karnon, Tracy L Merlin, Janet E Hiller.   

Abstract

Health systems can be improved appreciably by making them more efficient and accountable, and enhancing the quality of care, without necessarily requiring additional resources. Australia, like other nations, cannot escape making difficult health care choices in the context of resource scarcity, and the challenge of delivering quality care, informed by best available evidence, to an ageing population with multiple comorbidities. An opportunity exists for a cost-saving or cost-neutral agenda of reallocation of resources within the existing health budget, through reducing the use of existing health care interventions that offer little or no benefit relative to the cost of their public subsidy. This would allow reallocation of funding towards interventions that are more cost-effective, maximising health gain. Criteria based on those developed for health technology assessment (HTA) might facilitate the systematic and transparent identification of existing, potentially ineffective practices on which to prioritise candidates for assessment as to their cost-effectiveness. The process could be jointly funded by all relevant stakeholders but centrally administered, with HTA groups resourced to undertake identification and assessment and to liaise with clinicians, consumers and funding stakeholders.

Mesh:

Year:  2009        PMID: 19296794     DOI: 10.5694/j.1326-5377.2009.tb02394.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  40 in total

1.  The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis.

Authors:  Judith E Fisher; Ying Zhang; Ingrid Sketris; Grace Johnston; Fred Burge
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-11-14       Impact factor: 2.890

2.  Analysis of Physician Variation in Provision of Low-Value Services.

Authors:  Aaron L Schwartz; Anupam B Jena; Alan M Zaslavsky; J Michael McWilliams
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

3.  Difficult decisions in times of constraint: criteria based resource allocation in the Vancouver Coastal Health Authority.

Authors:  Craig Mitton; Francois Dionne; Rizwan Damji; Duncan Campbell; Stirling Bryan
Journal:  BMC Health Serv Res       Date:  2011-07-14       Impact factor: 2.655

Review 4.  Systematic reviews and health policy: the influence of a project on perinatal care since 1988.

Authors:  Daniel M Fox
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

Review 5.  Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review.

Authors:  Bonny Parkinson; Catherine Sermet; Fiona Clement; Steffan Crausaz; Brian Godman; Sarah Garner; Moni Choudhury; Sallie-Anne Pearson; Rosalie Viney; Ruth Lopert; Adam G Elshaug
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

6.  Low-Value Service Use in Provider Organizations.

Authors:  Aaron L Schwartz; Alan M Zaslavsky; Bruce E Landon; Michael E Chernew; J Michael McWilliams
Journal:  Health Serv Res       Date:  2016-11-10       Impact factor: 3.402

Review 7.  [The problem of medical overuse : Finding a definition and solutions].

Authors:  T Gamstätter
Journal:  Internist (Berl)       Date:  2021-02-13       Impact factor: 0.743

8.  A time-and-motion approach to micro-costing of high-throughput genomic assays.

Authors:  S Costa; D A Regier; B Meissner; I Cromwell; S Ben-Neriah; E Chavez; S Hung; C Steidl; D W Scott; M A Marra; S J Peacock; J M Connors
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

Review 9.  Reorienting programme budgeting and marginal analysis (PBMA) towards disinvestment.

Authors:  Duncan Mortimer
Journal:  BMC Health Serv Res       Date:  2010-10-14       Impact factor: 2.655

10.  The governance of standard-setting to improve health.

Authors:  Daniel M Fox
Journal:  Prev Chronic Dis       Date:  2010-10-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.